Clinical outcomes after spontaneous and nucleos(t)ide analogue-treated HBsAg seroclearance in chronic HBV infection

Clinical outcomes after interruption of entecavir therapy in HBeAg-negative chronic hepatitis B patients with compensated cirrhosis

(2015) Y. C. Chen et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir

(2015) Tse-Ling Fong et al.   DIGESTIVE DISEASES AND SCIENCES

AASLD guidelines for treatment of chronic hepatitis B

(2015) Norah A. Terrault et al.   HEPATOLOGY

Hepatitis B surface antigen seroclearance during nucleoside analogue therapy: surface antigen kinetics, outcomes, and durability

(2015) Wai-Kay Seto et al.   JOURNAL OF GASTROENTEROLOGY

Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance

(2015) Gi-Ae Kim et al.   JOURNAL OF HEPATOLOGY

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

(2015)   JOURNAL OF HEPATOLOGY

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

High Risk of Hepatitis B Virus Reactivation in Nucleos(t)ide Analogue-Induced Hepatitis B e Antigen Seroconverters Older Than 40 Years

(2014) Li-Fu Kuo et al.   DIGESTIVE DISEASES AND SCIENCES

Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

(2014) Maria Buti et al.   DIGESTIVE DISEASES AND SCIENCES

HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability

(2013) Gi-Ae Kim et al.   GUT

Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy

(2013) Wai-Kay Seto et al.   HEPATOLOGY

Seroclearance rate of hepatitis B surface antigen in 2,112 patients with chronic hepatitis in Japan during long-term follow-up

(2013) Mariko Kobayashi et al.   JOURNAL OF GASTROENTEROLOGY

Clinical and Virological Characteristics Post HBsAg Seroclearance in Hepatitis B Virus Carriers With Hepatic Steatosis Versus Those Without

(2012) Chia-Ming Chu et al.   DIGESTIVE DISEASES AND SCIENCES

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

(2012) Yun-Fan Liaw et al.   Hepatology International

Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study

(2012) Tetsuya Hosaka et al.   JOURNAL OF GASTROENTEROLOGY

Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients

(2011) R. Idilman et al.   JOURNAL OF VIRAL HEPATITIS

Hepatitis B surface antigen seroclearance during chronic HBV infection

(2010) Chia-Ming Chu et al.   ANTIVIRAL THERAPY

Nucleos(t)ide Analogues Only Induce Temporary Hepatitis B e Antigen Seroconversion in Most Patients With Chronic Hepatitis B

(2010) Jurriën G.P. Reijnders et al.   GASTROENTEROLOGY

Hepatitis B and hepatocellular carcinoma

(2010) Adrian M. Di Bisceglie   HEPATOLOGY

Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus

(2009) Josephine Simonetti et al.   HEPATOLOGY

Hepatitis B virus infection

(2009) Yun-Fan Liaw et al.   LANCET

HBsAg Seroclearance in Chronic Hepatitis B in Asian Patients: Replicative Level and Risk of Hepatocellular Carcinoma

(2008) Man–Fung Yuen et al.   GASTROENTEROLOGY